Updated:
King's Fund
Founded in 1897 as the Prince of Wales's Hospital Fund for London, The King's Fund was incorporated by royal charter in 2008 and has operated for over a...
King's Fund
Founded in 1897 as the Prince of Wales's Hospital Fund for London, The King's Fund was incorporated by royal charter in 2008 and has operated for over a century as an endowed charitable foundation focused exclusively on health and care in England. HM King Charles III has served as its President since 1986. The Fund is governed by a Board of Trustees chaired by the Rt Hon Professor Lord Kakkar, with Sarah Woolnough appointed as Chief Executive. The Fund's work straddles three domains: policy research and analysis, leadership development for NHS and social care professionals, and convening power that brings together government, the NHS, and the private sector. Its endowment, estimated at $217M, is allocated across a diversified portfolio including private equity, infrastructure, and direct real estate holdings in London and Hampshire. Known investment vehicles and partners include the GSK IMPACT Awards program, a long-running collaboration with GlaxoSmithKline that recognizes community health charities, and co-published research with the Nuffield Trust on the British Social Attitudes survey. The investment strategy spans buyout and fund-of-funds commitments, with the real estate portfolio comprising 11-13 Cavendish Square and 7-10 Dean's Mews in London, plus the Old Basing Estate in Hampshire. The Fund maintains a Corporate Partners and Supporters program that enrolls businesses into health policy debate and provides a recurring revenue stream separate from the endowment drawdown. While total professional headcount is not publicly disclosed, the organization operates from its Cavendish Square headquarters. No additional offices are maintained outside London. No recent operational event was identified in the last 24 months from available sources. The King's Fund is structurally distinct among UK health philanthropies: it holds a royal charter, a directly managed real asset portfolio, and an explicit investment program in private markets — all in service of a domestic policy mission rather than medical research or direct care delivery. This hybrid endowment-plus-operating-charity model gives it a permanence and independence that grant-funded think tanks lack, while its royal patronage and deep NHS relationships provide access that purely financial endowments cannot replicate.
General information
Firm type
Endowment / Foundation
Year founded
1897
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
11-13 Cavendish Square, London, W1G 0AN, United Kingdom
Principals
Sarah Woolnough
Chief Executive Officer
Rt Hon Professor Lord Kakkar
Chair of the Board of Trustees
HM King Charles III
President
Sector focus
Frequently asked questions
Who runs investment decisions at The King's Fund?
The Fund does not publicly name a dedicated CIO or investment committee. Governance rests with the Board of Trustees chaired by Lord Kakkar, with CEO Sarah Woolnough holding executive authority. The investment portfolio spans real estate, private equity, and infrastructure, but no external investment office or outsourced CIO mandate is publicly disclosed.
How is The King's Fund's endowment invested?
The endowment, estimated at $217M, is allocated across a mix of private equity (buyout and fund-of-funds strategies), infrastructure, and direct real estate. Known property holdings include the Cavendish Square headquarters, Dean's Mews commercial space, and the Old Basing Estate in Hampshire. No breakdown by asset class or manager is publicly available.
What is The King's Fund's relationship with the NHS?
The King's Fund is an independent charity, not part of the NHS. It functions as a policy think tank, leadership development body, and convener of health system leaders. Its research and recommendations shape NHS policy, and it runs programs for NHS managers and clinicians, but it holds no statutory role in NHS governance or funding allocation.
Where does The King's Fund's wealth come from?
The Fund was originally established in 1897 with donations including a substantial gift from Sir Henry Burdett. Today its resources derive from the investment returns on its accumulated endowment, supplemented by income from its Corporate Partners program and grants from health-focused foundations and companies. No single wealth-origin family is associated with the Fund.
Does The King's Fund have a philanthropic foundation structure?
The King's Fund is itself a charitable foundation incorporated by royal charter. It does not operate a separate grantmaking foundation, but it partners with funders such as the Health Foundation and GlaxoSmithKline on specific programs like the GSK IMPACT Awards and joint research initiatives.
What is The King's Fund's known posture on co-investments?
The Fund's investment model includes both direct real estate holdings and fund commitments in private markets, but no co-investment activity alongside external GPs is publicly disclosed. Its private equity exposure appears to be accessed through fund-of-funds and direct fund commitments rather than direct co-investment or club deal structures.
Which sectors does The King's Fund explicitly avoid?
No explicit exclusionary policy is publicly disclosed. Given the Fund's charitable mission focused on health and care in England, its private market investments in private equity, infrastructure, and real estate are likely managed through a conventional ESG or responsible-investing lens, but no sector-specific prohibitions have been stated.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: